Nashville-based US Radiosurgery, a developer and operator of full-body radiosurgical facilities in cooperation with community hospitals and physicians, has formed a new nonprofit clinical research organization that will examine and compare the effectiveness of various radiation treatment modalities in combating cancer.

 

The Radiosurgical Research Institute will initiate clinical studies and collect treatment data from radiosurgery centers throughout the country to establish best practices, increase patient educational resources and provide radiosurgery centers with more clinical data to improve treatment recommendations.

 

US Radiosurgery CEO George Stevens said the institute was inspired by a relatively small amount of research and funding dedicated to comparing the effectiveness of treatment modalities, including conventional surgery, radiation therapy and chemotherapy, among others. Renowned radiation oncologist Luther Brady, MD, medical director of Philadelphia CyberKnife, has been named to lead the Radiosurgical Research Institute’s clinical review board. “The institute will welcome physicians and researchers from all radiosurgery facilities, regardless of affiliations,” Dr. Brady said. “Our purpose is to generate the best clinical research and scientific study of radiosurgery possible for the benefit of cancer patients and their doctors.”

 

More information is available at www.usradiosurgery.com